These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 6295008

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.
    Klein E, Masucci MG.
    Springer Semin Immunopathol; 1982; 5(1):63-73. PubMed ID: 6314570
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro.
    Sugden B.
    Rev Infect Dis; 1982; 4(5):1048-61. PubMed ID: 6293034
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.
    Strang G, Rickinson AB.
    Immunology; 1987 Dec; 62(4):647-54. PubMed ID: 2828228
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G, Rickinson AB.
    Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
    [Abstract] [Full Text] [Related]

  • 11. Immune surveillance against Epstein-Barr virus.
    Moss DJ, Burrows SR, Khanna R, Misko IS, Sculley TB.
    Semin Immunol; 1992 Apr; 4(2):97-104. PubMed ID: 1377517
    [Abstract] [Full Text] [Related]

  • 12. The effect of tinidazole on primary EBV infection and immunocompetence.
    Marklund G, Ernberg I, Britton S, Lundberg C.
    Scand J Infect Dis; 1984 Apr; 16(1):17-23. PubMed ID: 6320359
    [Abstract] [Full Text] [Related]

  • 13. Plasmacytic differentiation of circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis.
    Robinson JE, Smith D, Niederman J.
    J Exp Med; 1981 Feb 01; 153(2):235-44. PubMed ID: 6264016
    [Abstract] [Full Text] [Related]

  • 14. The changing faces of EBV research.
    Klein G, Klein E.
    Prog Med Virol; 1984 Feb 01; 30():87-106. PubMed ID: 6087416
    [No Abstract] [Full Text] [Related]

  • 15. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis.
    Tosato G, Magrath I, Koski I, Dooley N, Blaese M.
    N Engl J Med; 1979 Nov 22; 301(21):1133-7. PubMed ID: 226884
    [Abstract] [Full Text] [Related]

  • 16. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M, Myc A, Matej H, Rudzka L.
    Arch Immunol Ther Exp (Warsz); 1983 Nov 22; 31(6):871-8. PubMed ID: 6331340
    [Abstract] [Full Text] [Related]

  • 17. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK, Haworth SJ, Cohen J, Mundin J, Rickinson A, Sissons JG.
    Q J Med; 1986 Feb 22; 58(226):111-21. PubMed ID: 3012622
    [Abstract] [Full Text] [Related]

  • 18. Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis.
    Royston I, Sullivan JL, Periman PO, Perlin E.
    N Engl J Med; 1975 Dec 04; 293(23):1159-63. PubMed ID: 171568
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis.
    Wang F, Blaese RM, Zoon KC, Tosato G.
    J Clin Invest; 1987 Jan 04; 79(1):7-14. PubMed ID: 3025263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.